Exploiting malaria drug resistance to our advantage

Science

Volumn 333, Issue 6043, 2011, Pages 705-706

  Cammack, Nick ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; GENE PRODUCT; PYRIMETHAMINE; SULFADOXINE;

ANTIMALARIAL AGENT; CHEMICAL ANALYSIS; DRUG RESISTANCE; GENETIC ANALYSIS; MALARIA;

CROSS RESISTANCE; DRUG RESEARCH; DRUG TARGETING; HIGH THROUGHPUT SCREENING; MALARIA; PARASITE; PLASMODIUM; PRIORITY JOURNAL; SHORT SURVEY; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; EVOLUTION; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; GENOME; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NOTE; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; BIOLOGICAL EVOLUTION; DRUG COMBINATIONS; DRUG RESISTANCE; GENES, PROTOZOAN; GENETIC LINKAGE; GENOME, PROTOZOAN; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT SCREENING ASSAYS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 79961235070     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1210875     Document Type: Short Survey

References (9)

1. K. J. Cortez, F. Maldarelli, Viruses 3, 347 (2011).
2. J. Yuan et al., Science 333, 724 (2011).
3. WHO, Guidelines for Treatment of Malaria (World Health Organization, Geneva, ed. 2, 2010).
4. D. J. Johnson et al., Mol. Cell 15, 867 (2004).
5. K. Hayton, X.-Z. Su, Curr. Genet. 54, 223 (2008).
6. I. K. Srivastava, J. M. Morrisey, E. Darrouzet, F. Daldal, A. B. Vaidya, Mol. Microbiol. 33, 704 (1999).
7. F. J. Gamo et al., Nature 465, 305 (2010).
8. W. A. Guiguemde et al., Nature 465, 311 (2010).
9. D. Plouffe et al., Proc. Natl. Acad. Sci. U.S.A. 105, 9059 (2008).